These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 33119168)

  • 1. Predictors and outcomes of histological remission in ulcerative colitis treated to endoscopic healing.
    Jangi S; Yoon H; Dulai PS; Valasek M; Boland BS; Jairath V; Feagan BG; Sandborn WJ; Singh S
    Aliment Pharmacol Ther; 2020 Sep; 52(6):1008-1016. PubMed ID: 33119168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incremental Benefit of Achieving Endoscopic and Histologic Remission in Patients With Ulcerative Colitis: A Systematic Review and Meta-Analysis.
    Yoon H; Jangi S; Dulai PS; Boland BS; Prokop LJ; Jairath V; Feagan BG; Sandborn WJ; Singh S
    Gastroenterology; 2020 Oct; 159(4):1262-1275.e7. PubMed ID: 32585306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic mucosal healing and histologic remission in ulcerative colitis: a systematic literature review of clinical, quality-of-life and economic outcomes.
    Pandey A; Achrafie L; Kodjamanova P; Tencer T; Kumar J
    Curr Med Res Opin; 2022 Sep; 38(9):1531-1541. PubMed ID: 35608153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histologic remission does not offer additional benefit for ulcerative colitis patients in endoscopic remission.
    Narula N; Aruljothy A; Alshahrani AA; Fadida M; Al-Saedi M; Marshall JK; Rubin DT; Christensen B
    Aliment Pharmacol Ther; 2020 Dec; 52(11-12):1676-1682. PubMed ID: 33131108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of Relapse in Patients With Ulcerative Colitis With Persistent Endoscopic Healing: A Durable Treatment Endpoint.
    Jangi S; Holmer AK; Dulai PS; Boland BS; Collins AE; Pham L; Sandborn WJ; Singh S
    J Crohns Colitis; 2021 Apr; 15(4):567-574. PubMed ID: 32914194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histologic Remission (NANCY Index) is Superior to Endoscopic Mucosal Healing in Predicting Relapse Free Survival in Patients With Ulcerative Colitis in Clinical and Endoscopic Remission.
    Wang H; Fewings I; Bornman L; Shadbolt B; Fadia M; Subramaniam K
    J Clin Gastroenterol; 2023 May-Jun 01; 57(5):494-500. PubMed ID: 35220375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histologic improvement predicts endoscopic remission in patients with ulcerative colitis.
    Kim JE; Kim M; Kim MJ; Kim ER; Hong SN; Chang DK; Ha SY; Kim YH
    Sci Rep; 2024 Aug; 14(1):19926. PubMed ID: 39198522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors and Etiologies of Clinical Relapse Among Patients With Ulcerative Colitis in Deep Remission.
    Zeina T; Gandhi S; Mittal A; Levy AN; Weinstock J; Singh S; Jangi S
    J Clin Gastroenterol; 2024 Feb; 58(2):195-199. PubMed ID: 36753459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histologic Evaluation Using the Robarts Histopathology Index in Patients With Ulcerative Colitis in Deep Remission and the Association of Histologic Remission With Risk of Relapse.
    Park J; Kang SJ; Yoon H; Park J; Oh HJ; Na HY; Lee HS; Shin CM; Park YS; Kim N; Lee DH
    Inflamm Bowel Dis; 2022 Nov; 28(11):1709-1716. PubMed ID: 35016209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus for remission induction in ulcerative colitis: Mayo endoscopic subscore 0 and 1 predict long-term prognosis.
    Ikeya K; Sugimoto K; Kawasaki S; Iida T; Maruyama Y; Watanabe F; Hanai H
    Dig Liver Dis; 2015 May; 47(5):365-71. PubMed ID: 25682993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PICaSSO virtual electronic chromendoscopy accurately reflects combined endoscopic and histological assessment for prediction of clinical outcomes in ulcerative colitis.
    Nardone OM; Bazarova A; Bhandari P; Cannatelli R; Daperno M; Ferraz J; Goetz M; Gui X; Hayee B; De Hertogh G; Lazarev M; Li J; Parra-Blanco A; Pastorelli L; Panaccione R; Occhipinti V; Rath T; Smith SCL; Shivaji UN; Tontini GE; Vieth M; Villanacci V; Zardo D; Bisschops R; Kiesslich R; Ghosh S; Iacucci M
    United European Gastroenterol J; 2022 Mar; 10(2):147-159. PubMed ID: 35194978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Risk of Relapse in Ulcerative Colitis According to the Degree of Mucosal Healing (Mayo 0 vs 1): A Longitudinal Cohort Study.
    Barreiro-de Acosta M; Vallejo N; de la Iglesia D; Uribarri L; Bastón I; Ferreiro-Iglesias R; Lorenzo A; Domínguez-Muñoz JE
    J Crohns Colitis; 2016 Jan; 10(1):13-9. PubMed ID: 26351390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Endoscopic and Histologic Activity on Disease Relapse in Ulcerative Colitis.
    Bessissow T; Kron CM; Marcus V; Lemieux C; Laneuville J; Afif W; Wild G; Lakatos PL; Brassard P; Bitton A
    Am J Gastroenterol; 2022 Oct; 117(10):1632-1638. PubMed ID: 35862833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adalimumab for Induction of Histological Remission in Moderately to Severely Active Ulcerative Colitis.
    Fernández-Blanco JI; Fernández-Díaz G; Cara C; Vera MI; Olivares D; Taxonera C
    Dig Dis Sci; 2018 Mar; 63(3):731-737. PubMed ID: 29372480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histologic Normalization Occurs in Ulcerative Colitis and Is Associated With Improved Clinical Outcomes.
    Christensen B; Hanauer SB; Erlich J; Kassim O; Gibson PR; Turner JR; Hart J; Rubin DT
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1557-1564.e1. PubMed ID: 28238954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The sensitivity of fecal calprotectin in predicting deep remission in ulcerative colitis.
    Carlsen K; Riis LB; Elsberg H; Maagaard L; Thorkilgaard T; Sørbye SW; Jakobsen C; Wewer V; Florholmen J; Goll R; Munkholm P
    Scand J Gastroenterol; 2018; 53(7):825-830. PubMed ID: 29968483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis.
    Urushikubo J; Yanai S; Nakamura S; Kawasaki K; Akasaka R; Sato K; Toya Y; Asakura K; Gonai T; Sugai T; Matsumoto T
    World J Gastroenterol; 2018 Oct; 24(38):4384-4392. PubMed ID: 30344422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.
    Zittan E; Kelly OB; Kirsch R; Milgrom R; Burns J; Nguyen GC; Croitoru K; Van Assche G; Silverberg MS; Steinhart AH
    Inflamm Bowel Dis; 2016 Mar; 22(3):623-30. PubMed ID: 26829408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship Between Combined Histologic and Endoscopic Endpoints and Efficacy of Ustekinumab Treatment in Patients With Ulcerative Colitis.
    Li K; Marano C; Zhang H; Yang F; Sandborn WJ; Sands BE; Feagan BG; Rubin DT; Peyrin-Biroulet L; Friedman JR; De Hertogh G
    Gastroenterology; 2020 Dec; 159(6):2052-2064. PubMed ID: 32853634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up.
    Bryant RV; Burger DC; Delo J; Walsh AJ; Thomas S; von Herbay A; Buchel OC; White L; Brain O; Keshav S; Warren BF; Travis SP
    Gut; 2016 Mar; 65(3):408-14. PubMed ID: 25986946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.